RC

Rob E. Coleman

Advisory Board Chairman at Inbiomotion

Dr. Coleman is Emeritus Professor of Medical Oncology at Weston Park Hospital and the University of Sheffield, UK. Dr. Coleman has been instrumental in developing clinical cancer research and in establishing an internationally respected bone oncology research team in Sheffield. Dr. Coleman has held many leadership roles within the university and the UK National Institute for Health Research (NIHR) Cancer Research Network. Dr. Coleman has developed a highly successful cancer clinical trials facility, which has both led and participated in a broad range of clinical trials-ranging from early phase drug development studies to large phase III randomised trials. In 2020, Dr. Colemen and co-workers published the ESMO Clinical Practice Guidelines for bone health in cancer.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Inbiomotion

Inbiomotion is a personalized medicine company developing biomarkers that can predict bone metastasis in cancers.


Headquarters

Barcelona, Spain

Employees

1-10

Links